Community Initiative

We aim to become the most admirable business in any community we operate; we can achieve this by the cordial relationship we build with our host. Because we want the many communities we work in to grow alongside us as our business grows, they reciprocate this by providing an enabling environment that helps our business continued growth. The symbiotic alliances we build with communities help us to plan and implement our growth strategies.

Our community health care initiative alongside the voluntary work of our committed employees helps to improve health care awareness and healthcare access & delivery within our host communities

Community Initiative

Pharmaceuticals News

Aug 28, 2014 European Commission Grants Orphan Drug Designation to Soliris® (eculizumab) for the Treatment of Patients with Myasthenia Gravis (MG)

European Commission Grants Orphan Drug Designation to Soliris® (eculizumab) for the Treatment of Patients with Myasthenia Gravis (MG)European Commission Grants Orphan Drug Designation to Soliris® (eculizumab) for the Treatment of Patients with Myas

More News
For General
Enquiries Call Us on + 234 (0) 7020687006